Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS??? EQUITY (UNAUDITED)

v3.20.1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($)
Series A Preferred Stock
Series B Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning Balance, Shares at Dec. 31, 2018 185 52 134,793,211      
Beginning Balance, Amount at Dec. 31, 2018 $ 1,340,566 $ 362,059 $ 134,792 $ 127,570,709 $ (123,171,406) $ 6,236,720
Shares issued directors, shares 292,308      
Shares issued to directors, value $ 294 35,708 36,002
Stock-based compensation expense related to employee stock options 1,815 1,815
Net income attributable to common stockholders (845,604) (845,604)
Ending Balance, Shares at Mar. 31, 2019 185 52 135,085,519      
Ending Balance, Amount at Mar. 31, 2019 $ 1,340,566 $ 362,059 $ 135,086 127,608,232 (124,017,010) 5,428,933
Beginning Balance, Shares at Dec. 31, 2019 185 52 135,990,491      
Beginning Balance, Amount at Dec. 31, 2019 $ 1,340,566 $ 362,059 $ 135,990 127,708,773 (125,105,539) 4,441,849
Shares issued directors, shares 320,844      
Shares issued to directors, value $ 321 17,679 18,000
Stock-based compensation expense related to employee stock options 1,815 1,815
Net income attributable to common stockholders (652,501) (652,501)
Ending Balance, Shares at Mar. 31, 2020 185 52 136,311,335      
Ending Balance, Amount at Mar. 31, 2020 $ 1,340,566 $ 362,059 $ 136,311 $ 127,728,267 $ (125,758,040) $ 3,809,163